Pseudohypoaldosteronism type II, also known as Gordon hyperkalemia-hypertension syndrome, is characterized by hyperkalemia despite normal renal glomerular filtration, hypertension, and correction of physiologic abnormalities by thiazide diuretics. Mild hyperchloremia, metabolic acidosis, and suppressed plasma renin activity are variable associated findings.[supplied by OMIM, Jul 2002]
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
PHA2A-20-RE | 20 (40 μL) | 200 μL | Request Pricing | |
PHA2A-20-OR | 20 (40 μL) | 200 μL | Request Pricing | |
PHA2A-20-GO | 20 (40 μL) | 200 μL | Request Pricing | |
PHA2A-20-GR | 20 (40 μL) | 200 μL | Request Pricing | |
PHA2A-20-AQ | 20 (40 μL) | 200 μL | Request Pricing |
Pseudohypoaldosteronism type II, also known as Gordon hyperkalemia-hypertension syndrome, is characterized by hyperkalemia despite normal renal glomerular filtration, hypertension, and correction of physiologic abnormalities by thiazide diuretics. Mild hyperchloremia, metabolic acidosis, and suppressed plasma renin activity are variable associated findings.[supplied by OMIM, Jul 2002]
Gene Symbol : PHA2A
Gene Name : Pseudohypoaldosteronism type II (gene A)
Chromosome : CHR 1: 0-0
Locus : 1q31-q42
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.